232 related articles for article (PubMed ID: 37762416)
1. The Role of Regulatory T Cells in Cancer Treatment Resistance.
Dąbrowska A; Grubba M; Balihodzic A; Szot O; Sobocki BK; Perdyan A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762416
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?
Liu J; Zhang B; Zhang G; Shang D
Front Immunol; 2024; 15():1345838. PubMed ID: 38449875
[TBL] [Abstract][Full Text] [Related]
3. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
4. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
[TBL] [Abstract][Full Text] [Related]
5. Treg programming and therapeutic reprogramming in cancer.
Moreno Ayala MA; Li Z; DuPage M
Immunology; 2019 Jul; 157(3):198-209. PubMed ID: 30866047
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review.
Wu X; Zhou Z; Cao Q; Chen Y; Gong J; Zhang Q; Qiang Y; Lu Y; Cao G
Front Immunol; 2023; 14():1268188. PubMed ID: 37753092
[TBL] [Abstract][Full Text] [Related]
8. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.
Nishikawa H; Koyama S
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330764
[TBL] [Abstract][Full Text] [Related]
10. Natural Plant Products Mediated Prevention of Cancer Facilitated through Immune Suppression of Treg Cells.
Mukherjee O; Rakshit S; Shanmugan G; Sarkar K
Curr Top Med Chem; 2023; 23(30):2973-2986. PubMed ID: 37937579
[TBL] [Abstract][Full Text] [Related]
11. Treg-mediated acquired resistance to immune checkpoint inhibitors.
Saleh R; Elkord E
Cancer Lett; 2019 Aug; 457():168-179. PubMed ID: 31078738
[TBL] [Abstract][Full Text] [Related]
12. The relationship between regulatory T cells and radiation therapy.
Hou PF; Zhu LJ; Pan Y; Sun XC; Pu J
Cancer Radiother; 2020 Feb; 24(1):81-84. PubMed ID: 32046914
[TBL] [Abstract][Full Text] [Related]
13. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
Beauford SS; Kumari A; Garnett-Benson C
BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with regulatory T and B cells in periodontitis.
Zou J; Zeng Z; Xie W; Zeng Z
Int Immunopharmacol; 2022 Aug; 109():108797. PubMed ID: 35487085
[TBL] [Abstract][Full Text] [Related]
15. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
16. Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Overacre-Delgoffe AE; Vignali DAA
Cancer Immunol Res; 2018 Aug; 6(8):882-887. PubMed ID: 30068755
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
19. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets.
Yang XF
Front Biosci; 2008 Jan; 13():1472-99. PubMed ID: 17981643
[TBL] [Abstract][Full Text] [Related]
20. Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy.
Munn DH; Sharma MD; Johnson TS
Cancer Res; 2018 Sep; 78(18):5191-5199. PubMed ID: 30181177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
